Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 911-694-8 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1986
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Renowned laboratory following protocol equivalent to OECD guideline
Data source
Referenceopen allclose all
- Reference Type:
- publication
- Title:
- Inactivity of glycerol formal in a mouse micronucleus assay: relationship to its teratogenicity
- Author:
- Ashby J. & Ratpan F.
- Year:
- 1 986
- Bibliographic source:
- Environmental Mutagenesis, 8: 873-877
- Reference Type:
- publication
- Title:
- Evaluation of some formaldehyde-release compounds and other biocides in the mouse micronucleus test
- Author:
- Richardson C.R., Styles J.A. & Burlinson B.
- Year:
- 1 983
- Bibliographic source:
- Mutation Research, 124: 241-246
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Deviations:
- no
- GLP compliance:
- no
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- Glycerol formal
- IUPAC Name:
- Glycerol formal
- Details on test material:
- Glycerol formal was purchased from Lancaster Synthesis Limited, Morcambe, UK and was providedas a mixture of 1,2- and 1,3-acetal in 1:3 ratio.
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- C57BL
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: not specified
- Age at study initiation: 6-8 weeks
- Weight at study initiation: not specified
- Assigned to test groups randomly: [no/yes, under following basis: ]
- Fasting period before study:
- Housing: 5 per cage
- Diet (e.g. ad libitum): Porton Combined Diet supplied by BP Nutrition Ltd., Stepfield, Whitam, Essex, Great Britain, ad libitum
- Water (e.g. ad libitum): water ad libitum
- Acclimation period: not specified
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20-22
- Humidity (%): 29-58
- Air changes (per hr): not specified
- Photoperiod (hrs dark / hrs light): 12/12
IN-LIFE DATES: not specified
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- None
- Vehicle(s)/solvent(s) used: corn oil - Details on exposure:
- Not specified
- Duration of treatment / exposure:
- 24 and 48h
- Frequency of treatment:
- daily
- Post exposure period:
- None
Doses / concentrationsopen allclose all
- Remarks:
- Doses / Concentrations:
1870 and 3000 mg/kg
Basis:
nominal conc.
For males and females in the First study
- Remarks:
- Doses / Concentrations:
1620 and 2600 mg/kg
Basis:
nominal conc.
For males in the Second study
- Remarks:
- Doses / Concentrations:
3125 and 5000 mg/kg
Basis:
nominal conc.
For females in the Second study
- No. of animals per sex per dose:
- 5
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- cyclophosphamide
- Route of administration: oral gavage
- Doses / concentrations: 10 ml/kg
Examinations
- Tissues and cell types examined:
- Bone marrows
- Details of tissue and slide preparation:
- CRITERIA FOR DOSE SELECTION:
In STUDY 1, mice were treated with 80 and 50% of the 7-day maximum tolerated dose (MTD-7) level as a single gavage bolus in corn oil. Due to the high toxicity of these doses towards males, a more accurate determination of the MTD-7 was made separately for males and females in STUDY 2.
TREATMENT AND SAMPLING TIMES ( in addition to information in specific fields):
A AJOUTER
DETAILS OF SLIDE PREPARATION:
Bone marrow smears were prepared using the paintbrush technique, 24 and 48 hours after a single gavage dose of the test chemical or the positive control agent. Slides were stained with Giemsa and read blind, 1000 polychromatic erythrocytes (PE) being assessed for micronucleated polychromatic erythrocytes (MPE) per animal.
METHOD OF ANALYSIS:
In STUDY 1, cells for assessment were selected from areas of slide rich in PE. As a re-analysis, selected slides from the first study were reassessed for the incidence of MPE. This involved assessment of 10000 PE per slide, reading in continuous fields accross the smear, starting from the beginning of the smear.
In STUDTY 2, 1000 PE were assessed for MPE, starting at the beginning of the smear.
These different methods of slide assessment were due to changes made to Central Toxicology Laboratory test protocol. - Evaluation criteria:
- Statistics were the only criteria used to evaluate GF clastogenicity.
- Statistics:
- Differences between control and treated groups were assessed using single-sided Students t-test
Results and discussion
Test results
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- yes
- Remarks:
- Only mortality was recoded (number of surviving animals/initial number of animals). For males: 4/5 at 1870 mg/kg at 24h sampling; 0/5 at 3000 mg/kg at 24h sampling; 2/5 at 3000 mg/kg at 48h sampling; 4/5 at 1620 mg/kg at 24h and 48h. For females: 4/5 at 1
- Vehicle controls validity:
- valid
- Negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- FIRST STUDY
Mice were treated with GF at 1870 and 3000 mg/kg. As shown in Table 1 (in "Any other information on results incl. tables"), these dose levels were too much toxic to males.
SECOND STUDY
Due to toxicity met in first study, revised dose levels were employed.
Both studie showed no evidence of clastogenic response of GF. The inactivity of GF was confirmed when selected slides from the first study were assessed more extensively (using 10000 PE rather than 1000 PE) as shown in Table 3.
Statistical evaluation
No statistically significant differences were established between vehicle control and GF treatments groups whereas statistically significant differences were established between vehicle control and cyclophosphamide positive control groups (p < 0.001), using a single-sided Studentst-test (Tables 1 and 2).
Any other information on results incl. tables
Table 1: Incidence of Micronucleated Polychromatic Erythrocytes (MPE) per 1000 Polychromatic Erythrocytes (PE) at the 2 sampling times shown for glycerol formal (GF), corn oil and cyclophosphamide (CP)
Treatment |
MPE/ 1000 PE ± SD (number of animals) |
|||
24 h sampling |
48 h sampling |
|||
Male |
Female |
Male |
Female |
|
Corn oil (10 ml/kg) |
3.80 ± 1.1 (5) |
2.0 ± 1 (5) |
3.80 ± 2.1 (5) |
2.20 ± 1.3 (5) |
CP (65 mg/kg) |
33.20 ± 5.8* (5) |
29.80 ± 3.03* (5) |
23.0 ± 0.9 (5) |
15.20 ± 2.3* (5) |
GF (1870 mg/kg) |
1.75 ± 0.96 (4) |
1.75 ± 0.5 (4) |
3.40 ± 0.9 (5) |
1.50 ± 1.0 (5) |
GF (3000 mg/kg) |
- (0) |
2.50 ± 1.3 (4) |
3.50 (2) |
2.80 ± 1.5 (5) |
*Statistically significantly different from controls, p <0.001 (single-sided Student t-test)
Table 2: Incidence of MPE/ 1000 PE at the 2 sampling times shown for glycerol formal (GF), corn oil and cyclophosphamide (CP)
Treatment |
MPE/ 1000 PE ± SD (number of animals) |
||||
24 h sampling |
48 h sampling |
24 hr/48 h male/female (comnined) |
|||
Male |
Female |
Male |
Female |
||
Corn oil (10 ml/kg) |
2.4 ± 1.1 (5) |
1.2 ± 1.3 (5) |
1.4 ± 1.1 (5) |
1.2 ± 0.8 (5) |
1.55 ± 1.14 (20) |
CP (65 mg/kg) |
13.2 ± 1.5* (5) |
10.0 ± 1* (5) |
15.4 ± 1.9 (5) |
10.2 ± 1.8* (5) |
13.7 ± 4.2* (20) |
GF (1870 mg/kg) |
1.25 ± 0.96 (4) |
|
2.4 ± 0.56 (4) |
|
1.34 ± 1.14 (18) |
GF (3000 mg/kg) |
|
0.75 ± 0.96 (5) |
|
0.8 ± 1.1 (5) |
|
GF (3000 mg/kg) |
2.2 ± 0.84 (5) |
|
1.8 ± 1.6 (5) |
|
1.35 ± 1.34 (20) |
GF (3000 mg/kg) |
- |
1.0 ± 1 (5) |
|
0.2 ± 0.45 (5) |
*Statistically significantly different from controls, p <0.001 (single-sided Student t-test)
Table 3: Results of re-analysing selected slides from animals included in Table 1, such that 10 000 PE, instead of 1000 PE, were assessed per slide
Test group |
MPE/ 1000 PE |
|||
Original values (1000 PE) |
Original mean ± SD |
Values from extended assessment (10 000 PE) |
Final mean ± SD |
|
48h, female, vehicle control |
4, 1, 2 |
2.3 ± 1.5 |
1.6, 1.4, 2.0 |
1.7 ± 0.3 |
48h, male, vehicle control |
6, 2.6 |
4.7 ± 2.3 |
3.3, 2.9, 3.5 |
3.2 ± 0.3 |
48h, male, CP |
31 |
|
18.8 |
|
48h, male, GF |
4, 4, 4 |
4 ± 0 |
3.5, 2.5, 2.7 |
2.90 ± 0.5 |
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): negative
The mammalian erythrocyte micronucleus test showed no evidence of a clastogenic response of glycerol formal. - Executive summary:
The mammalian erythrocyte micronucleus test was performed on mice C57BL in 2 times to identify clastogenic potential of glycerol formal (GF).
In the first study, male and female mice were treated with GF at 1870 and 3000 mg/kg by oral gavage route (single dose). Due to high GF toxicity towards males, a second study was performed with the following concentrations in GF: 1620 and 2600 mg/kg for males and 3125 and 5000 mg/kg for females. In both studies, corn oil (at 10 ml/kg) and cyclophosphamide (at 65 mg/kg) were used as vehicle and positive control, respectively respectivelyNumber of Micronucleated Polychromatic Erythrocytes (MPE) per 1000 Polychromatic Erythrocytes (PE) were assessd at 24- and 48 -hour sampling.
In both studies, no statistically significant differences were established between vehicle control and GF treatments groups whereas statistically significant differences were established between vehicle control and cyclophosphamide positive control groups (p < 0.001), using a single-sided Studentst-test (Tables 1 and 2).
The mammalian erythrocyte micronucleus test showed no evidence of a clastogenic response of glycerol formal.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.